91 related articles for article (PubMed ID: 36307813)
1. Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis.
Wang X; Ma T; Zhang W; Chu Q
Chin Med; 2022 Oct; 17(1):122. PubMed ID: 36307813
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.
Wang Q; Zhu H; Li M; Liu Y; Lai H; Yang Q; Cao X; Ge L
Front Pharmacol; 2021; 12():688857. PubMed ID: 34456720
[No Abstract] [Full Text] [Related]
3. Qingfei Paidu decoction for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials.
Zhang Y; Xie H; Li Y; Li T; Yuan H; Fu X; Xie C
Medicine (Baltimore); 2020 Sep; 99(36):e22040. PubMed ID: 32899063
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese Medicine for COVID-19: A Network Meta-Analysis and Systematic Review.
Ji Z; Hu H; Qiang X; Lin S; Pang B; Cao L; Zhang L; Liu S; Chen Z; Zheng W; Liu C; Wang H; Zhang J
Am J Chin Med; 2022; 50(4):883-925. PubMed ID: 35729086
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of outcomes in COVID-19 patients treated with western medicine in combination with traditional Chinese medicine versus western medicine alone.
Yu R; Zhang S; Zhao D; Yuan Z
Expert Rev Mol Med; 2022 Jan; 24():e5. PubMed ID: 34986905
[TBL] [Abstract][Full Text] [Related]
6. Protection effects of mice liver and lung injury induced by coronavirus infection of Qingfei Paidu decoction involve inhibition of the NLRP3 signaling pathway.
Huang W; Chen X; Yin M; Li J; Luo M; Ai Y; Xie L; Li W; Liu Y; Xie X; Chen Y; Zhang X; He J
J Ethnopharmacol; 2024 Mar; 321():117512. PubMed ID: 38040130
[TBL] [Abstract][Full Text] [Related]
7. Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis.
Zhang L; Ma Y; Shi N; Tong L; Liu S; Ji X; Chen R; Fan Y; Liang N; Ge Y; Gao H; Chen G; Wang W; Zhang H; Wang Y; Wang Y
Phytomedicine; 2022 Jul; 102():154166. PubMed ID: 35636170
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.
Li L; Wang X; Guo X; Li Y; Song Q; Li A
Front Pharmacol; 2022; 13():1013428. PubMed ID: 36210820
[TBL] [Abstract][Full Text] [Related]
9. Effect and Mechanism of Qingfei Paidu Decoction in the Management of Pulmonary Fibrosis and COVID-19.
Wu Y; Xu L; Cao G; Min L; Dong T
Am J Chin Med; 2022; 50(1):33-51. PubMed ID: 34931591
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Integrated Traditional Chinese and Western Medicine for Treating COVID-19: A Systematic Review and Meta-Analysis of RCTs.
Yin B; Bi YM; Sun L; Huang JZ; Zhao J; Yao J; Li AX; Wang XZ; Fan GJ
Front Public Health; 2021; 9():622707. PubMed ID: 34307269
[No Abstract] [Full Text] [Related]
11. Chinese Medicine for Coronavirus Disease 2019 (COVID-19): A GRADE-Assessed Systematic Review and Meta-Analysis.
Guo J; Qin Z; Lau NC; Fong TL; Meng W; Zhang ZJ; Luo Y; Wong VCT; Feng Y; Chen H
Am J Chin Med; 2022; 50(1):1-31. PubMed ID: 34931587
[TBL] [Abstract][Full Text] [Related]
12. [Meta analysis on the treatment of coronavirus disease 2019 by traditional Chinese and Western medicine].
Wang Q; Mei J; Wang C; Wu L; Gao H; Zhang H; Chen F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):714-720. PubMed ID: 34296692
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. [Rationality of Asari Radix et Rhizoma in Qingfei Paidu Decoction based on literature analysis].
Qin ZN; Wang MX; Shi NN; Wang YP; Zhai HQ
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1515-1520. PubMed ID: 32489028
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of Qingfei Paidu decoction combined with antiviral drugs in the treatment of corona virus disease 2019: A protocol for systematic review and meta analysis.
Gao K; Song YP; Chen H; Zhao LT; Ma L
Medicine (Baltimore); 2020 May; 99(22):e20489. PubMed ID: 32481460
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided drug design combined network pharmacology to explore anti-SARS-CoV-2 or anti-inflammatory targets and mechanisms of Qingfei Paidu Decoction for COVID-19.
Wang Z; Zhan J; Gao H
Front Immunol; 2022; 13():1015271. PubMed ID: 36618410
[TBL] [Abstract][Full Text] [Related]
17. Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
Du XQ; Shi LP; Cao WF; Chen ZW; Zuo B; Hu JY
Front Pharmacol; 2021; 12():708636. PubMed ID: 34603023
[No Abstract] [Full Text] [Related]
18. Evidence Mapping of 23 Systematic Reviews of Traditional Chinese Medicine Combined With Western Medicine Approaches for COVID-19.
Zhang T; Li X; Chen Y; Zhao L; Tian J; Zhang J
Front Pharmacol; 2021; 12():807491. PubMed ID: 35197851
[No Abstract] [Full Text] [Related]
19. Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.
Jiang F; Xu N; Zhou Y; Song J; Liu J; Zhu H; Jiang J; Xu Y; Li R
Phytother Res; 2021 Nov; 35(11):5992-6009. PubMed ID: 34256418
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of Qingfei Paidu decoction in patients with coronavirus disease 2019 acute pneumonia after treatment: a protocol for systematic review and Meta-analysis.
Rong F; Haoyu HE; Tao T; Hanjin C
J Tradit Chin Med; 2023 Oct; 43(6):1068-1071. PubMed ID: 37946468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
